Protein Electrophoresis – CSF (Oligoclonal Bands) Test

The Protein Electrophoresis – CSF (Oligoclonal Bands) test examines cerebrospinal fluid for restricted bands of immunoglobulin, particularly immunoglobulin G or IgG. Cerebrospinal fluid, commonly called CSF, is the clear liquid that surrounds and protects the brain and spinal cord. Oligoclonal bands can indicate immune activity occurring within the central nervous system.

The test is most commonly used to support the investigation of multiple sclerosis and other inflammatory, infectious or immune-mediated neurological disorders. It does not independently diagnose multiple sclerosis or identify the precise cause of inflammation. Results must be interpreted with symptoms, neurological examination, MRI findings and other blood and CSF investigations.

For the most reliable interpretation, a CSF sample is usually analysed together with a serum sample collected at approximately the same time. Comparing CSF and serum patterns helps determine whether immunoglobulin bands are being produced within the central nervous system or are part of a systemic immune response that has entered the CSF.

What Are Oligoclonal Bands?

Antibodies are proteins produced by immune cells. When a limited group of immune-cell clones produces antibodies, the proteins may appear as several distinct bands during high-resolution electrophoresis or isoelectric focusing. These restricted bands are called oligoclonal bands.

Oligoclonal bands found in CSF but absent from paired serum can indicate intrathecal immunoglobulin production. Intrathecal means that the antibodies are being produced within the central nervous system rather than simply entering CSF from the bloodstream.

The presence of CSF-restricted bands supports central nervous system inflammation but is not specific to one disease. Similar findings can occur in multiple sclerosis, certain infections, autoimmune neurological disorders and other inflammatory conditions.

How Does Oligoclonal Band Testing Work?

The laboratory uses a high-resolution protein-separation method, commonly isoelectric focusing, followed by immunodetection of IgG. Proteins separate according to their electrical characteristics, creating a banding pattern that can be visually compared between CSF and serum.

When bands are present in CSF but not in serum, the pattern suggests immunoglobulin production within the central nervous system. When matching bands occur in both CSF and serum, the finding may represent a systemic immune response rather than central nervous system-restricted production.

Testing methods, positivity criteria and pattern classifications can vary between laboratories. Some laboratories consider two or more unique CSF IgG bands a positive result, while reports from other laboratories may use different validated thresholds. The interpretation provided by the performing laboratory should be followed.

Why Is This Test Performed?

A healthcare professional may request CSF oligoclonal band testing when multiple sclerosis or another inflammatory neurological condition is suspected. The test may provide supporting evidence when symptoms and MRI findings suggest demyelination but further confirmation is required.

The test may also be included in the evaluation of infections affecting the central nervous system, autoimmune encephalitis, neurosyphilis, inflammatory myelitis and selected chronic neurological disorders. It cannot identify a particular infectious organism or distinguish every inflammatory condition.

Oligoclonal band testing is generally more sensitive for detecting restricted IgG production than routine CSF protein electrophoresis. However, a positive result remains nonspecific, and a negative result does not completely exclude multiple sclerosis or another inflammatory disorder.

Who May Need This Test?

The test may be considered for patients with neurological symptoms suggestive of demyelination or central nervous system inflammation. These can include episodes of blurred or reduced vision, pain with eye movement, numbness, tingling, weakness, balance difficulty, muscle stiffness or impaired coordination.

Other possible symptoms include unexplained neurological episodes separated in time, bladder dysfunction, unusual fatigue, cognitive changes or electric-shock-like sensations with neck movement. These symptoms can occur in many conditions and do not establish a diagnosis of multiple sclerosis.

A neurologist may request the test after reviewing the patient's clinical history, examination and MRI. Lumbar puncture is not required for every person being assessed for multiple sclerosis. The decision depends on how much additional information CSF analysis is expected to provide.

Testing may also be appropriate when chronic infection, inflammatory encephalitis, transverse myelitis or another immune-mediated neurological condition is being investigated. The complete CSF panel is selected according to the suspected disorder.

What Samples Are Required?

A cerebrospinal fluid sample is required and is generally obtained through a lumbar puncture. For accurate pattern comparison, a paired venous blood sample may also be required. The blood should usually be collected close to the time of the lumbar puncture.

The laboratory separates serum from the blood sample and compares serum IgG bands with those found in CSF. Without a paired serum sample, determining whether bands are unique to CSF can be more difficult, and interpretation may be limited.

CSF must be placed in a sterile, securely closed and correctly labelled container. Serum must be submitted in the tube specified by the laboratory. Required volumes, processing conditions, storage and transportation requirements should be confirmed before sample collection.

How Is Cerebrospinal Fluid Collected?

CSF is usually collected through a lumbar puncture, also called a spinal tap. The patient is positioned lying on one side or sitting while leaning forward. The lower back is cleaned, and a local anaesthetic may be administered to reduce discomfort.

A thin needle is inserted between the bones of the lower spine into the fluid-containing space. A small amount of CSF is collected into sterile tubes. The needle is placed below the level where the spinal cord usually ends, reducing the risk of direct spinal-cord injury.

The procedure must be performed by a trained healthcare professional in an appropriate clinical setting. In selected patients, examination, imaging or blood-clotting tests may be required before lumbar puncture.

Risks Associated with Lumbar Puncture

The laboratory analysis itself does not create physical risk. The principal risks are related to the lumbar puncture. A post-lumbar-puncture headache may occur and is often worse when sitting or standing. Temporary back discomfort or tenderness can also develop.

Less common complications include bleeding, infection, nerve irritation or persistent CSF leakage. Patients using anticoagulants or medicines that affect clotting must inform the treating clinician. Medicines should not be stopped without medical instructions.

Patients should follow the clinical team's guidance regarding preparation, positioning and aftercare. Medical advice should be sought if severe headache, fever, worsening back pain, weakness, numbness, fluid leakage or significant bleeding occurs after the procedure.

Is Fasting Required?

Fasting is generally not required specifically for CSF oligoclonal band testing. However, fasting may be required if sedation, another procedure or additional blood investigations are planned. Patients should follow the preparation instructions supplied by the clinical facility.

A complete list of medicines should be provided before lumbar puncture. Blood thinners and medicines affecting platelets or clotting are particularly important. Only the treating doctor should decide whether any medicine requires adjustment.

Understanding Oligoclonal Band Patterns

The report may state whether oligoclonal bands are present and whether they are unique to CSF or matched in serum. Some laboratories also assign a pattern type based on the relationship between CSF and serum bands.

No bands in either CSF or serum generally indicates that no restricted IgG pattern was detected by the method. This does not exclude multiple sclerosis, inflammation or infection because some affected patients may have negative oligoclonal band results.

Bands restricted to CSF suggest intrathecal IgG production. This pattern is commonly associated with multiple sclerosis but can also occur with infectious and autoimmune diseases of the central nervous system.

Matching bands in CSF and serum may reflect systemic immunoglobulin production with movement of antibodies across the blood-CSF barrier. This pattern is not equivalent to CSF-restricted synthesis.

A combination of matching bands and additional CSF-restricted bands can indicate both a systemic immune response and local central nervous system immunoglobulin production. A single monoclonal-type pattern may require correlation with serum immunofixation or haematological evaluation.

What Does a Positive Result Mean?

A positive result generally means that the laboratory detected the required number of IgG bands in CSF that were absent from serum. This finding supports intrathecal immunoglobulin synthesis and indicates immune activity within the central nervous system.

A positive result does not confirm multiple sclerosis. It must be interpreted with the patient's neurological history, examination and MRI. Multiple sclerosis requires evidence that disease activity has affected different parts of the central nervous system at different times or other findings that satisfy accepted diagnostic criteria.

Positive CSF-restricted bands can also occur with central nervous system infections, autoimmune encephalitis, neurosyphilis, neuroborreliosis, inflammatory myelitis and selected systemic autoimmune conditions affecting the nervous system.

What Does a Negative Result Mean?

A negative result means that the test did not identify a qualifying CSF-restricted oligoclonal band pattern. It may reduce support for intrathecal IgG production but does not completely exclude multiple sclerosis or another neurological disease.

The timing of testing, analytical method, immunoglobulin concentration and individual disease characteristics may affect detection. If clinical suspicion remains high, the neurologist will rely on MRI, follow-up examinations and other laboratory findings rather than repeating testing automatically.

Oligoclonal Bands and Multiple Sclerosis

Multiple sclerosis is a chronic inflammatory disorder in which the immune system damages myelin and other structures in the brain, spinal cord and optic nerves. Symptoms and disease patterns vary considerably between patients.

CSF-restricted oligoclonal bands are commonly found in patients with multiple sclerosis, but they are not unique to the condition. Their presence provides evidence of intrathecal immune activity and may contribute to diagnosis when considered with a typical clinical presentation and MRI findings.

Some patients with confirmed multiple sclerosis do not have detectable oligoclonal bands. Therefore, the absence of bands should not be used alone to rule out the disease. Similarly, treatment should never be started based only on a positive CSF result.

Oligoclonal Bands Versus CSF IgG Index

The CSF IgG index and oligoclonal band test both assess aspects of intrathecal immunoglobulin production, but they use different approaches. Oligoclonal band testing is qualitative and evaluates restricted band patterns.

The IgG index is a calculated quantitative result using CSF IgG, serum IgG, CSF albumin and serum albumin. It estimates whether the amount of IgG in CSF is higher than expected based on blood-CSF barrier transfer.

One test may be abnormal when the other is not. Depending on the clinical question, the doctor may request both. Neither test independently diagnoses multiple sclerosis.

Factors That Can Affect Test Interpretation

• Failure to submit a paired serum sample.
• Serum collected at a substantially different time from CSF.
• Blood contamination during a traumatic lumbar puncture.
• Insufficient CSF or serum volume.
• Incorrect specimen labelling or container selection.
• Delayed transport or unsuitable sample storage.
• Very low immunoglobulin concentration in the specimen.
• Recent intravenous immunoglobulin or blood-product treatment.
• Systemic infection or autoimmune activity causing matching bands.
• Differences between laboratory methods and positivity thresholds.

Possible Follow-Up Tests

Depending on the result and clinical presentation, additional testing may include the CSF IgG index, total CSF protein, albumin quotient, cell count, glucose, Gram stain, culture and molecular tests for infectious organisms.

Immunofixation, cytology or flow cytometry may be requested when a monoclonal protein or malignancy is suspected. Serum protein electrophoresis and serum immunofixation can help determine whether an abnormal protein pattern is systemic.

MRI of the brain and spinal cord is important when multiple sclerosis, myelitis or another structural neurological condition is suspected. Blood tests may be performed to identify infections, vitamin deficiencies, autoimmune conditions and other disorders that can resemble demyelinating disease.

Benefits and Limitations

The principal benefit of oligoclonal band testing is its ability to detect restricted immunoglobulin production within the central nervous system. It may provide valuable supporting evidence when symptoms and imaging suggest an inflammatory neurological disorder.

The main limitation is lack of disease specificity. A positive test does not determine whether the cause is multiple sclerosis, infection or another inflammatory condition. A negative result does not completely exclude these disorders.

The test also requires an invasive CSF collection procedure, and reliable interpretation commonly requires paired serum. Results should be assessed by a neurologist or another qualified specialist.

When Should Urgent Medical Care Be Sought?

Urgent medical evaluation is required for severe headache with fever, neck stiffness, confusion, seizures, sudden weakness, loss of consciousness or rapidly worsening neurological symptoms. These may indicate meningitis, encephalitis, stroke or another emergency.

After lumbar puncture, seek medical guidance for severe or persistent positional headache, fever, increasing back pain, weakness, numbness, fluid leakage or significant bleeding. Patients should follow all aftercare instructions supplied by the clinical team.

Booking and Laboratory Information

The listed price for Protein Electrophoresis – CSF (Oligoclonal Bands) is ₹700. Before arranging sample collection, confirm the current price, paired-serum requirement, minimum CSF volume, container specifications, transport conditions and expected reporting time.

The displayed price may cover laboratory analysis only. It may not include consultation, hospital charges, the lumbar puncture procedure, local anaesthesia, imaging, consumables or additional CSF and blood tests. This investigation should be performed only after a qualified clinician has requested it.